[
  {
    "ts": null,
    "headline": "Zoetis Receives European Commission Marketing Authorization for Lenivia速 (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs",
    "summary": "PARSIPPANY, N.J., November 26, 2025--Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia速 (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs.",
    "url": "https://finnhub.io/api/news?id=003a36870a53a1f851e70d1496c2c419698d7da7b485872be076b22a7f828c6c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764191700,
      "headline": "Zoetis Receives European Commission Marketing Authorization for Lenivia速 (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs",
      "id": 137619254,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZTS",
      "source": "Yahoo",
      "summary": "PARSIPPANY, N.J., November 26, 2025--Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia速 (izenivetmab) for the reduction of pain associated with osteoarthritis (OA) in dogs.",
      "url": "https://finnhub.io/api/news?id=003a36870a53a1f851e70d1496c2c419698d7da7b485872be076b22a7f828c6c"
    }
  }
]